SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- eGain (Nasdaq: EGAN), the AI Knowledge Management platform for business, today announced financial results for its fiscal 2025 first quarter ended September 30, 2024. “We are pleased to report positive …
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering …
GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the closing of its previously announced underwritten public …
LOUISVILLE, Ky., Nov. 12, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced …
MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home …
Awarded $65.7 Million Final Judgment in Trial Against Cisco Cash Balance of $12.1 Million at September 30, 2024 JERICHO, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Paltalk, Inc. (“Paltalk,” the “Company,” “we,” “our” or “us”) (Nasdaq: PALT), a communications …
-- Grew revenue 28% year-over-year to $21.1 million in Q3 2024 -- -- Increased full-year 2024 revenue guidance to $78 million to $80 million -- -- Demonstrated continued operating discipline through further decrease in cash burn -- -- Management scheduled …
HIGH POINT, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company with a portfolio of novel small molecules and a lead program in diabetes, today reported financial results for the third …
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial …
Sequential Revenue Growth of 33% Quarter-Over-Quarter Adjusted EBITDA Growth of 255% to $0.2 million1 Year-Over-Year, at 2% Margin1 Net Income Growth of 194% to $1.5 million Year-Over-Year EPS Growth of 132% to $0.73 Year-Over-Year TAMPA, Fla., Nov. 12, …
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today provided a corporate update on the expected submission date …
DENVER, Nov. 12, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended September 30, 2024. Third Quarter …
FDA approval of MIPLYFFA™ and product launch cap third quarter filled with multiple commercial and clinical development milestones Zevra received rare pediatric disease Priority Review Voucher Company ends quarter with cash, cash equivalents and …
A unique tailgating experience at MetLife Stadium merges game-day excitement with meaningful conversations on mental health EAST RUTHERFORD, NJ, UNITED STATES, November 12, 2024 /EINPresswire.com/ -- Football season just got a whole lot more meaningful …
SPRINGFIELD, Mo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced that its Board of Directors has declared a cash dividend of 23 cents ($0.23) per share on its outstanding common stock. The action was taken on November 11 …
Author Stephan Mayhew shares difficulties of personal decision-making, life-changing consequences, and the journey toward self-understanding. NEW YORK CITY, NY, UNITED STATES, November 12, 2024 /EINPresswire.com/ -- In his latest novel, My Women, My …
VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a company specializing in commercial-stage regenerative medicine and pioneering devices for wound care management and skin restoration, today announced it has …
Sales Season Yields Over 80 New Clients, 1.1 Million New Covered Lives Selected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner 1.5 Million Lives Adopt Newest Services in Maternity and/or Menopause Programs in 2025 …
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 Company reports topline safety results from ENLIGHTEN 1 Phase 3 extension study indicating no product-related serious adverse events …
CHICAGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (NASDAQ: MRCC) today announced its financial results for the third quarter ended September 30, 2024. Except where the context suggests otherwise, the terms “Company,” “we,” “us,” and “ …
